FluoGuide A/S

Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.

FLUO | ST

Overview

Corporate Details

ISIN(s):: DK0061123312
LEI:: 89450078OGAJQ84J9R62
Country:: Denmark
Address:: Ole Maaløes Vej 3, 2200 København N
Website:: https://fluoguide.com/
Sector:: Professional, scientific and technical activities
Industry:: Research and experimental development on natural sciences and engineering

Description

FluoGuide A/S is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through precision surgery. The company develops drugs that make cancer cells fluorescent during surgical procedures. Its lead product, FG001, is designed to 'light up' cancer, enabling surgeons to more accurately distinguish and remove malignant tissue while preserving healthy surrounding tissue. By enhancing surgical precision, FluoGuide aims to reduce the rate of cancer recurrence, minimize complications, and lower overall healthcare costs associated with readmissions and further treatments. The company's technology is based on a proprietary uPAR-targeted platform and is currently being evaluated in clinical trials for various types of cancer.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for FluoGuide A/S and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all FluoGuide A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for FluoGuide A/S via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
1NKEMIA Offers contract R&D, develops tech platforms, and invests in life sciences ventures.	Spain	IKM
2cureX AB Tests cancer drugs on patient-derived micro-tumors for personalized oncology treatments.	Sweden	2CUREX
4SC AG Developing epigenetic small-molecule drugs for cancers with high unmet medical needs.	Germany	VSC
Abera Bioscience AB Develops next-gen mucosal vaccines using an OMV platform for major infectious diseases.	Sweden	ABERA
ABIVAX Developing oral drugs for chronic inflammatory diseases like ulcerative colitis and Crohn's disease.	France	ABVX
Abliva A clinical-stage biotech developing medicines for rare primary mitochondrial diseases.	Sweden	ABLI
Achiko AG A liquidated health tech firm that developed aptamer diagnostics and a COVID-19 passport app.	Switzerland	ACHI
Acticor Biotech Biopharma developing first-in-class drugs for acute stroke and other thrombotic diseases.	France	ALACT
Active Biotech Develops immunotherapies for cancer and inflammatory diseases with significant unmet needs.	Sweden	ACTI
Addex Therapeutics Ltd Develops oral small molecule drugs, allosteric modulators, for neurological disorders.	Switzerland	ADXN